Skip to content
Company Spotlight

Medpace Expands Medical Leadership in Nephrology

  • October 5, 2022
Medpace is pleased to announce the addition of three new medical experts to its nephrology medical leadership team. Our unique, scientifically-driven approach to clinical research gives Sponsors the advantage of early and ongoing insight and guidance from trial design through execution of the study. With the addition of these highly-qualified physicians, Medpace can offer Sponsors even deeper expertise across a broad spectrum of diseases and technologies.

Ineta Sosare, MD, PED, NEP – Medical Director

Dr. Ineta Sosare is a board-certified nephrologist and pediatrician with more than 18 years of therapeutic expertise gleaned from her roles as a physician and in academia. She brings extensive medical monitoring experience in phase II-III global studies in autoimmune disorders, glomerulonephritis, chronic kidney disease, kidney transplant, and pediatric trials including phenylketonuria, familial hypercholesterolemia, and infantile hemangioma. In her previous roles, Dr. Sosare provided medical expertise to project teams on clinical drug development, throughout the lifecycle of compounds, including supporting study design and generating study protocol.

Dr. Sosare received her medical degree from the Medical Academy of Latvia in Rida, Latvia. She continued her education at the Medical Academy of Latvia, receiving diplomas in Nephrology and Pediatrics.

Sudha Alphonse, RN, NMP, MSc, PGCert, Dip GNM – Advanced Clinical Practitioner

Ms. Alphonse is a NMC registered Nurse (Adult), Teacher and Nurse Prescriber providing support to the Medpace Clinical Operations and Medical Monitor teams focused in Nephrology. Ms. Alphonse has 14 years of clinical renal specialized experience including Dialysis – Haemodialysis and Peritoneal, Vascular access complications, Renal Transplantation, Plasma Exchange, Low Clearance Clinics, and providing expert nephrology consultations in both outpatient and inpatient environments for conditions such as Acute Kidney Injury, various stages of Chronic Kidney Disease, Hepatorenal syndrome, Autoimmune diseases within the leading private healthcare facility and national healthcare services. This experience was enriched by the nephrology specialized qualifications, advanced assessment, prescribing, and educational qualifications from the renowned King’s College London, and provides guest lectures for the Renal Course module.

In collaboration with the Medpace Medical Monitors, Ms. Alphonse as an ACP engages throughout the life of the clinical trials. Ms. Alphonse supports the study activities by providing therapeutic and clinical expertise, team training, and offers insight into best practices to identify and recruit trial subjects.

Prudence King, MSN, AGPCNP-BC – Advanced Clinical Practitioner

Ms. King is a board-certified adult gerontology primary care nurse practitioner providing support to the Medpace Clinical Operations and Medical Monitor teams focused in Nephrology.  Ms. King has over 28 years of clinical renal specialized experience including dialysis for adults and pediatrics- hemodialysis and peritoneal, CAVH/CVVH, and providing expert nephrology consultations in both outpatient and inpatient environments for conditions such as acute kidney injury and various stages of chronic kidney disease. Additionally, she served as Clinical Director of Dialysis, where she managed the day-to-day operation of a sixteen-chair outpatient dialysis center, a two-bed inpatient unit, and peritoneal dialysis clinic. In addition, Ms. King also has extensive experience in public health nursing including home care, hospice, and palliative care.

Ms. King received her Master of Science in Nursing Education as well as her Post Masters Certificate degree from Keuka College. She is board certified and a member of the American Nephrology Nurses Association.

Deep Dive: Nephrology and Renal Disease

Medpace has built a team of therapeutically-aligned operations and regulatory experts who work collaboratively with our specialized medical team to manage and execute nephrology trials encompassing Sponsor/CRO project management and site study coordination from the patient care perspective. A best-fit, cross-functional team is assigned to each project upon initiation, and typically remains in place through trial completion, producing truly seamless drug development. We would welcome the opportunity to talk about your upcoming clinical development in Nephrology and Renal Diseases. Learn more about our capabilities in Nephrology and contact us to connect with our experts.